In this article NOVO.B-DK LLY Follow your favorite stocksCREATE FREE ACCOUNT George Frey | Reuters Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to
It’s no secret that Meta Platforms (NASDAQ:META) is in the crosshairs of regulators on more than one continent. Furthermore, META stock hasn’t broken through $400 yet, even though this should have happened by now. Just hang in there, though, as Meta Platforms won’t let you down if you just stay in the trade. I understand
Investors seem to be sliding down the wall of worry faster than they made a difficult climb. That usually means that investors will flee growth stocks in favor of income or value-oriented investments. With that in mind, it may be time to scan your portfolio for growth stocks to sell. So what is concerning
Thanks to Microsoft’s (NASDAQ:MSFT) $69 billion acquisition of Activision Blizzard on Oct. 14, Lululemon (NASDAQ:LULU) was chosen to replace it as one of the select S&P 500 stocks. As is usually the case when a stock is added to the index, LULU stock gained 10% on the news since funds that track the index must
Andrew Kelly | Reuters The bond vigilantes are coming back as investors continue to sell amid the prospect of higher-for-longer interest rates and a growing fiscal deficit, according to Kevin Zhao, head of global sovereign and currency at UBS Asset Management. The yield on the benchmark 10-year U.S. Treasury note rose above 5% once again
Elon Musk is under fire again. This time, it’s due to Tesla (NASDAQ:TSLA) itself, and shareholders are facing quite the heat as the stock has tumbled almost 20% from its October peak. However, even lifelong Tesla bulls agree this time is different. That’s because Elon Musk’s handling of the recent earnings call was very pessimistic
Investing in dividend stocks can be a great way to grow a retirement account. Compounding interest and reinvesting dividends into strong, financially secure companies can lead to an extensive and comprehensive investment portfolio around retirement if investors start dividend investing as early as possible. Every year of investing, especially at a young age, can lead
As circumstances sit right now, the concept of high-risk, high-reward retail stocks likely favors the bears more so than the contrarian bulls. Let’s be real: while the Federal Reserve has attacked inflation with aggressive interest rate hikes, consumer prices remain stubbornly high. So long as that’s the case, investing in the discretionary retail space will
Understandably, the concept of stocks to sell is a controversial one in the capital market. Let me rephrase that in baseball terms. As a manager, how long are you going to stay with a starting pitcher that just doesn’t have it? When you give up five runs in the first inning? How about 10? What’s
While the experts may be putting on a smile ahead of possible economic challenges, investors should be prepared with quality stocks with strong cash flow. Sure, we’re all hoping for a soft landing. However, with mass layoffs still occurring and consumer sentiment and consumer sentiment in the dumps compared to pre-pandemic levels, it’s time to
With a few exceptions, healthcare stocks have had a rough go of it in 2023. The Standards and Practices (S&P) 500 Healthcare Index is down 5% year to date, versus a 13% increase in the benchmark S&P 500 index. Most healthcare stocks are down across the board. Pharma companies, health insurers and medical device manufacturers
With Tesla (NASDAQ:TSLA) slow-walking the production of its Cybertruck and Rivian’s (NASDAQ:RIVN) deliveries zooming higher, RIVN stock is poised to jump. Its launch of a more affordable SUV and gross margin increases are also likely to help the start-up long term. Additionally, Rivian’s EVs have generally received excellent reviews. Amazon (NASDAQ:AMZN) has widely deployed its
If I’m looking to outperform the market over time, I’m usually going to buy growth stocks. While value stocks have a place in any portfolio, growth stocks are the ones that keep the returns rolling in. Usually, companies represented by growth stocks are innovative and quickly adapt to changing times. By being involved in some
When Hollywood writers went on strike it took a bite out of some entertainment stocks, but with a deal in place, these are safe stocks to buy now. The streaming space lost a lot of its shine over the past few weeks as the months long strike put a stop to many of the series
Investors encounter tough choices when it comes to EV leader Tesla (NASDAQ:TSLA). While I do think EVs represent the future and Elon Musk is widely-praised, the past two years have brought a reality check for growth investors. Indeed, TSLA stock can move in a direction that’s not up and to the right, evidenced by a
Alphabet (NASDAQ:GOOG) is one of the top growth stocks most investors either own (directly or via an index fund) or wish they had owned in recent years. This is a company that’s made impressive advancements in AI technology and is at the forefront of other high-growth businesses. Of course, the company’s core Google search business
It’s an old investing adage that investors should let their winners run. And that’s generally true. Historically, momentum has proven to be a powerful factor and stock prices that are in upward motion often tend to keep rising for a considerable length of time. However, there also comes a time for taking profits. At some
2023 has been a significantly better year as compared to 2022. However, several stocks have slipped amid the growing uncertainties and high-interest rates. The first half of the year was strong but the recent pullback has brought a solid opportunity to invest in some of the biggest stocks in the industry. It has led to
Biotechnology is the source of some of our strongest and growing revolutions. Gene technology allows us to cure incurable diseases and make miracles happen with living organisms. Immunotherapies promise targeted treatment without harmful side effects. And more and more, we are understanding the deep structure of cancers, allowing us to develop treatments that promise a
Anheuser-Busch InBev (NYSE:BUD) closed its $113 billion acquisition [pg. 45] of SABMiller on Oct. 10, 2016, a little over seven years ago. In that time, BUD stock has lost approximately 58% of its value. In 2015, Anheuser-Busch finished the year with $43.6 billion in revenue, while its normalized profit was $8.5 billion for a respectable